Targeting bone metastases starting from the preneoplastic niche: Home sweet home

Breast Cancer Research

Volumn 13, Issue 4, 2011, Pages

  Santini, Daniele ^a   Vincenzi, Bruno ^a   Pantano, Francesco ^a   Tonini, Giuseppe ^a   Bertoldo, Francesco ^b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BONE METASTASIS; CANCER CELL; CANCER STEM CELL; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; EDITORIAL; HUMAN; NONHUMAN; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; BONE TUMOR; CELL TRANSFORMATION; DRUG DESIGN; METABOLISM; METASTASIS; PATHOLOGY;

OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN;

BONE NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; CELLULAR MICROENVIRONMENT; DRUG DESIGN; HUMANS; NEOPLASTIC STEM CELLS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 80052717581     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2911     Document Type: Editorial

References (10)

1. Clézardin P. Therapeutic targets for bone metastases in breast cancer. Breast Cancer Res 2011, 13:207. 10.1186/bcr2835, 21586099.
2. Grimm J, Grimm W. The Complete Grimm's Fairy Tales 1944, New York: Pantheon Books.
3. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003, 3:895-902. 10.1038/nrc1232, 14737120.
4. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100:3983-3988. 10.1073/pnas.0530291100, 153034, 12629218.
5. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438:820-827. 10.1038/nature04186, 2945882, 16341007.
6. Ramaswamy S, Perou CM. DNA microarrays in breast cancer: the promise of personalised medicine. Lancet 2003, 361:1576-1577. 10.1016/S0140-6736(03)13322-3, 12747872.
7. Shimoyama A, Wada M, Ikeda F, Hata K, Matsubara T, Nifuji A, Noda M, Amano K, Yamaguchi A, Nishimura R, Yoneda T. Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol Biol Cell 2007, 18:2411-2418. 10.1091/mbc.E06-08-0743, 1924839, 17442891.
8. Gerritsen ME, Soriano R, Yang S, Ingle G, Zlot C, Toy K, Winer J, Draksharapu A, Peale F, Wu TD, Williams PM. In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set. Physiol Genomics 2002, 10:13-20.
9. Santini D, Perrone G, Roato I, Godio L, Pantano F, Grasso D, Russo A, Vincenzi B, Fratto ME, Sabbatini R, Della Pepa C, Porta C, Del Conte A, Schiavon G, Berruti A, Tomasino RM, Papotti M, Papapietro N, Onetti Muda A, Denaro V, Tonini G. Expression pattern of receptor activator of NFκB [RANK] in a series of primary solid tumors and related bone metastases. J Cell Physiol 2011, 226:780-784. 10.1002/jcp.22402, 20857484.
10. Santini D, Schiavon G, Vincenzi B, Gaeta L, Pantano F, Russo A, Ortega C, Porta C, Galluzzo S, Armento G, La Verde N, Caroti C, Treilleux I, Ruggiero A, Perrone G, Addeo R, Clezardin P, Muda AO, Tonini G. Receptor activator of NF-kB [RANK] expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. PLoS One 2011, 6:e19234. 10.1371/journal.pone.0019234, 3084800, 21559440.